Akums Drugs & Pharmaceuticals Ltd. (AKUMS) Share Price Near 52-Week High as Stock Traded at Rs 829.20
Updated: 7 Oct 2026 • 9:34 am
Posted by:
Akums Drugs & Pharmaceuticals Ltd. Share Price is trading at Rs 829.20, up 1.78% today, and remains close to its 52-week high. The company’s market capitalisation stands at Rs 12,600.96 crore. According to latest Univest data, the move keeps Akums Drugs & Pharmaceuticals Ltd. Share Price in focus for investors following Akums Drugs & Pharmaceuticals Ltd. Stock News, Akums Drugs & Pharmaceuticals Ltd. Share Price Today and broader Indian stock market updates.
As of 07 October 2026 at 9:22 AM IST, the latest Univest figures show the stock at Rs 829.20 versus a previous close of Rs 814.70, after opening at Rs 814.75 and touching Rs 832.30. That places Akums Drugs & Pharmaceuticals Ltd. Share Price very near its yearly high, which naturally draws attention in Healthcare and in the Pharmaceuticals & Drugs industry. The same price event also makes Akums Drugs & Pharmaceuticals Ltd. Share Price Today relevant for readers searching for Akums Drugs & Pharmaceuticals Ltd. Share Price Live, Akums Drugs & Pharmaceuticals Ltd. Share Price Update and Akums Drugs & Pharmaceuticals Ltd. Latest News.
Akums Drugs & Pharmaceuticals Ltd. Share Price Today: Price Action Analysis
The latest Univest data confirms the price event, but it does not establish a company-specific catalyst. What can be verified is the current share price, the intraday range and the valuation backdrop. For readers tracking Akums Drugs & Pharmaceuticals Ltd. Share News, Akums Drugs & Pharmaceuticals Ltd. NSE and Akums Drugs & Pharmaceuticals Ltd. BSE references, the key question is how the current price sits against its 52-week high, its sector benchmark and its reported financial ratios.
| Metric | Value |
|---|---|
| Current Price | Rs 829.2 |
| Previous Close | Rs 814.7 |
| Today's Move | +Rs 14.5 (+1.78%) |
| Open | Rs 814.75 |
| High | Rs 832.3 |
| Low | Rs 814.75 |
| Market Capitalisation | Rs 12,600.96 crore |
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) traded at Rs 829.2 versus the previous close of Rs 814.7, a rise of 1.78%. The stock opened at Rs 814.75, reached a high of Rs 832.3 and touched a low of Rs 814.75.
Akums Drugs & Pharmaceuticals Ltd. Share Price Today reflects a rise of Rs 14.50 from the previous close, with the stock last traded at Rs 829.20 after opening at Rs 814.75. The day’s low was Rs 814.75 and the high was Rs 832.30, so the share price remained near the upper end of the intraday range. With a market capitalisation of Rs 12,600.96 crore, Akums Drugs & Pharmaceuticals Ltd. Share Price Today is being watched in Stocks in News and 52 Week High Stocks conversations.
For a near-52-week-high event, the important point is not just the percentage move but the position of Akums Drugs & Pharmaceuticals Ltd. Share Price relative to that yearly high. The current level keeps the stock in view for readers following Akums Drugs & Pharmaceuticals Ltd. Share Price News, Akums Drugs & Pharmaceuticals Ltd. Share Price Live and Akums Drugs & Pharmaceuticals Ltd. Share Price Update. The latest Univest figures show that the stock is trading just below its one-year high zone, which explains why Akums Drugs & Pharmaceuticals Ltd. Stock News is drawing searches today.
This price action also matters because it places Akums Drugs & Pharmaceuticals Ltd. Share Price within a narrow band around its 52-week high, without turning the event into a record-high claim. Investors tracking Indian Stock Market movers may therefore focus on whether the stock keeps holding above the previous close and whether it continues to trade near the upper end of the day’s range as the session progresses.
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 12,600.96 crore |
| P/E Ratio | 43.96x |
| P/B Ratio | 3.75x |
| ROE | 8.06% |
| ROCE | 14.77% |
| EPS | Rs 18.53 |
| Book Value Per Share | Rs 216.98 |
| Dividend Yield | 0.37% |
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) fundamental metrics show P/E 43.96x, P/B 3.75x, ROE 8.06%, ROCE 14.77%. These figures provide context only and are not a buy or sell signal.
Akums Drugs & Pharmaceuticals Ltd. has a market capitalisation of Rs 12,600.96 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 43.96x, P/B at 3.75x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 8.06% and ROCE of 14.77%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 18.53, book value per share of Rs 216.98, dividend yield of 0.37%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.27x, median ROE of 11.73%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 43.96x |
| Benchmark Median P/E | 28.27x |
| Benchmark Average P/E | 41.13x |
| Benchmark P/E Range | 0x to 695.67x |
| Company P/B Ratio | 3.75x |
| Benchmark Median P/B | 2.86x |
| Company ROE | 8.06% |
| Benchmark Median ROE | 11.73% |
| Company ROCE | 14.77% |
| Benchmark Median ROCE | 13.46% |
| Company Market Capitalisation | Rs 12,600.96 crore |
| Benchmark Median Market Cap | Rs 789.87 crore |
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a P/E ratio of 43.96x, which is above the benchmark median of 28.27x, a difference of +55.5%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a ROE of 8.06%, which is below the benchmark median of 11.73%, a difference of -31.29%. Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a ROCE of 14.77%, which is above the benchmark median of 13.46%, a difference of +9.73%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| CORONA Remedies Ltd. | CORONA | 12,456.48 | 62.61 | 15.44 | 27.36 | 31.74 |
| Sudeep Pharma Ltd. | SUDEEPPHRM | 13,217.81 | 71.62 | 14.16 | 25.37 | 28.5 |
| Concord Biotech Ltd. | CONCORDBIO | 14,171.83 | 51.95 | 6.9 | 13.54 | 18.04 |
| Astrazeneca Pharma India Ltd. | ASTRAZEN | 14,958.13 | 88.19 | 16.54 | 23.02 | 31.24 |
| Marksans Pharma Ltd. | MARKSANS | 15,022.38 | 28.44 | 4.62 | 15.31 | 21.1 |
Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a P/E ratio of 43.96x compared with the displayed peer median of 62.61x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 8.06% compares with a peer median of 23.02% across the companies shown in the table. ROCE stood at 14.77% versus the displayed peer median of 28.5%, providing a capital-efficiency comparison. Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a market capitalisation of Rs 12,600.96 crore. Among the 5 peers shown, 4 have a larger market capitalisation.
Why Investors Are Watching Akums Drugs & Pharmaceuticals Ltd.
- Akums Drugs & Pharmaceuticals Ltd. Share Price is trading at Rs 829.20, with the day’s move at 1.78% and the stock near its 52-week high.
- Akums Drugs & Pharmaceuticals Ltd. Share Price Today is above the previous close of Rs 814.70 and inside the upper part of the intraday range.
- The company’s market capitalisation is Rs 12,600.96 crore, which helps position Akums Drugs & Pharmaceuticals Ltd. Share Price within Healthcare.
- P/E of 43.96 and P/B of 3.75 place Akums Drugs & Pharmaceuticals Ltd. Share Price above the industry median on both measures.
- ROCE of 14.77% is above the industry median of 13.46%, while ROE of 8.06% remains below the median of 11.73%.
About Akums Drugs & Pharmaceuticals Ltd.
Akums Drugs & Pharmaceuticals Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Akums Drugs & Pharmaceuticals Ltd. Share Price Today is therefore being tracked within a segment that is part of a broad listed healthcare universe. The latest Univest figures place the company among the industry names that are being monitored for price, valuation and sector context. For readers scanning Akums Drugs & Pharmaceuticals Ltd. Company News and Akums Drugs & Pharmaceuticals Ltd. Share News, that sector classification is the most direct company profile detail currently available.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
Why is Akums Drugs & Pharmaceuticals Ltd. Share Price in focus today?
What is the current Akums Drugs & Pharmaceuticals Ltd. Share Price today?
Ans. Akums Drugs & Pharmaceuticals Ltd. Share Price was last traded at Rs 829.20 as of 07 October 2026 at 9:22 AM IST. It moved above the previous close of Rs 814.70 during the session.
How far is Akums Drugs & Pharmaceuticals Ltd. Share Price from its yearly high?
Ans. Akums Drugs & Pharmaceuticals Ltd. Share Price is trading very close to its 52-week high zone. The day’s high was Rs 832.30, which keeps the stock near its yearly peak area.
What does Akums Drugs & Pharmaceuticals Ltd. fundamental analysis show?
Ans. Akums Drugs & Pharmaceuticals Ltd. fundamental analysis shows a P/E of 43.96, P/B of 3.75, ROE of 8.06%, ROCE of 14.77%, EPS of Rs 18.53 and book value of Rs 216.98.
How does Akums Drugs & Pharmaceuticals Ltd. compare with its industry?
Ans. Akums Drugs & Pharmaceuticals Ltd. Share Price sits above the industry median on P/E and P/B, while ROCE is also above the median. ROE, however, remains below the same-industry median.
What is the market cap of Akums Drugs & Pharmaceuticals Ltd.?
Ans. Akums Drugs & Pharmaceuticals Ltd. Market Cap is Rs 12,600.96 crore. That places the company above the industry market-cap median of Rs 789.87 crore and nearer larger peer values.
What does the PE ratio suggest for Akums Drugs & Pharmaceuticals Ltd. Share Price?
Ans. Akums Drugs & Pharmaceuticals Ltd. Share Price has a P/E of 43.96, above the same-industry median of 28.27 and slightly above the average of 41.13. That frames the valuation relative to peers.
Can investors track Akums Drugs & Pharmaceuticals Ltd. Share Price on Univest?
Ans. Yes. Univest tracks Akums Drugs & Pharmaceuticals Ltd. Share Price, 52-week levels, valuation ratios, market cap and broader stock updates. It is a useful reference for Akums Drugs & Pharmaceuticals Ltd. Stock News and share price updates.
Track Akums Drugs & Pharmaceuticals Ltd. Share Price on Univest
Use Akums Drugs & Pharmaceuticals Ltd. (AKUMS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
You can track Akums Drugs & Pharmaceuticals Ltd. Share Price on Univest for live price updates, 52-week levels, valuation ratios, market capitalisation, company fundamentals and market insights. Univest also helps readers follow Akums Drugs & Pharmaceuticals Ltd. Share Price Today, Akums Drugs & Pharmaceuticals Ltd. Stock News and Akums Drugs & Pharmaceuticals Ltd. Share Price Update in one place.
Recent Articles
Stocks to Buy for 2027: Ventura's Samvat 2083 Picks Include HDFC Bank, Paytm, Meesho, Ather, LG Electronics India and Park Medi World, With Targets Up to 75% Above the Price at Publication
13 November 2026
Microsoft Outage on 13 November 2026 Sends Traders Back to Phones and Fax: What the Outlook, Teams and Copilot Failure Means for Global Markets, Indian Brokerages and Investors
13 November 2026
Ingersoll Rand Dividend of Rs 20 Per Share: Record Date 19 November 2026, Payout on 2 December and What the Q2 FY27 Profit Rise of 9% Says About the Payout and the Stock
13 November 2026
Viceroy Hotels Share Price Gains Nearly 4% After Q2 FY27 Results: Revenue Up 56.5% to Rs 48.20 Crore but Profit Halves to Rs 2.23 Crore, and Why the Rs 106 Crore Rights Issue Matters on 13 November 2026
13 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Stocks to Buy for 2027: Ventura's Samvat 2083 Picks Include HDFC Bank, Paytm, Meesho, Ather, LG Electronics India and Park Medi World, With Targets Up to 75% Above the Price at Publication
Microsoft Outage on 13 November 2026 Sends Traders Back to Phones and Fax: What the Outlook, Teams and Copilot Failure Means for Global Markets, Indian Brokerages and Investors
Ingersoll Rand Dividend of Rs 20 Per Share: Record Date 19 November 2026, Payout on 2 December and What the Q2 FY27 Profit Rise of 9% Says About the Payout and the Stock
Viceroy Hotels Share Price Gains Nearly 4% After Q2 FY27 Results: Revenue Up 56.5% to Rs 48.20 Crore but Profit Halves to Rs 2.23 Crore, and Why the Rs 106 Crore Rights Issue Matters on 13 November 2026
SC Agrotech Bonus Issue and Stock Split: 4:5 Bonus and 1:10 Split Proposed as the Stock Locks a 5% Upper Circuit at Rs 62.38, Q2 Profit Up 48 Times and What Shareholders Should Check Before the 11 December EGM
Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times